Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

26,398 signal articles · 257 in last 24h · 126,655 total before filter · latest 57m ago
257last 24h
1197last 7d
187● bullish (7d)
123● bearish (7d)
205publishers
AllMacro233Earnings445M&A89Regulatory22Product12Analyst7
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
What CoreWeave's Q1 earnings mean for Nvidia
Yahoo Finance Video111d agoneutralVIDEO
What CoreWeave's Q1 earnings mean for Nvidia

CoreWeave (CRWV) reported first quarter results on Thursday and missed Wall Street's guidance expectations. EMJ Capital founder and president Eric Jackson and Yahoo Finance Senior Business Reporter Ines Ferré chat with Yahoo Finance's Brian Sozzi about the earnings results and the outlook for Nvidia (NVDA) and artificial intelligence (AI) demand.

Investing.com111d agoneutral
Analysts cut Trade Desk ratings after weak Q2 guidance signals growth slowdown

Investing.com -- The Trade Desk was hit with downgrades from three Wall Street firms on Thursday after the digital advertising platform's second-quarter guidance came in below expectations, raising fears of a sustained deceleration in growth amid agency tensions, competitive pressures, and Middle East-related ad spending headwinds.

Gilead (GILD) Q1 2026 Earnings Call Transcript
Motley Fool111d agoneutral
Gilead (GILD) Q1 2026 Earnings Call Transcript

As we execute on the strongest pipeline in our history, Gilead Sciences, Inc. is also taking steps to further strengthen the company's position for the future. The ongoing success of the Esthugo launch is a key driver of this growth in HIV prevention, with first quarter sales growing 72% sequentially. Looking forward, with no major LOEs until 2036, Gilead Sciences, Inc.'s HIV business is poised for strong, durable growth supported by up to seven potential new HIV product launches by 2033.

Reuters111d agoneutral
Amazon's Chile data center moves ahead after residents lose environmental challenge

Patricio Hernandez lives on the northern outskirts of Chile's capital Santiago, a hilly area below the Andes mountains which he and other residents fear could be ‌devastated by a major Amazon data center complex. He and other residents tried to ​block the data center, arguing the permit did not take into account the potential construction of a high-voltage power line that they said would be needed to feed the site. Environmental authorities in early April ruled the data center could move ahead, saying that any plans for a power line should be assessed separately.

Investing.com111d agoneutral
Rubio says US should hear Iran response today

Investing.com -- Secretary of State Marco Rubio said Friday that the United States expects to receive a response from Iran regarding negotiations, stating "we should hear something today."

Global equity funds draw inflows for the seventh week on earnings optimism
Reuters111d agoneutral
Global equity funds draw inflows for the seventh week on earnings optimism

May 8 () - Global equity funds attracted inflows for a seventh straight week in the period through May 6, supported ‌by upbeat first quarter earnings and hopes for a ‌U.35 billion of global equity funds during the week, ​though this was the smallest weekly inflow since March 18, LSEG Lipper data showed.

Treasury Yields Hold Range After Jobs Data
The Wall Street Journal111d agoneutral
Treasury Yields Hold Range After Jobs Data

U.S. Treasury yields are choppy following a stronger-than-expected April jobs report. While the economy added more jobs than anticipated last month, bond investors were taking the data in stride. Many have become less worried about the labor market in recent months and shifted their focus to energy prices and the state of U.

Investing.com111d agoneutral
Wells Fargo upgrades one, cuts two apparel stocks in sector reshuffle

Investing.com -- Wells Fargo on Friday reshuffled its ratings across the U.S. apparel and retail sector, upgrading Victoria’s Secret and downgrading Nike and Deckers, arguing that the rapid adoption of GLP-1 weight-loss drugs is impacting consumer spending in ways that favor clothing over footwear and athletic wear.